Sunshine Biopharma (SBFM) Other Operating Expenses (2016 - 2025)

Sunshine Biopharma (SBFM) posted Other Operating Expenses of -$7.0 for Q4 2025, up 99.93% on a QoQ basis from -$10250.0 in Q3 2025.

Sunshine Biopharma (SBFM) Other Operating Expenses (2016 - 2025) Analysis & Trends

Sunshine Biopharma's Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$7.0 for Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to -$7.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$10257.0 (changed N/A YoY) and the FY2025 annual result came in at -$10257.0, changed N/A from the prior year.
Other Operating Expenses was -$7.0 for Q4 2025 at Sunshine Biopharma, up from -$10250.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at -$7.0 in Q4 2025 and bottomed at -$10250.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	89.28 Bn	87.42 Bn	-
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn
10	Sunshine Biopharma	750,608.81	-6.16 Mn	2.18 Mn

Download Data